"A Clinical Study of Alambushadi Churna and Shatyadi Kashay in patients of Amvata vis-a-vis Rheumatoid Arthritis"
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- ï‚·Both the drugs of the study are expected to be effective because these are mentioned specifically in Amvataprakran in classical text and all constituents are having properties opposite to Ama dosha Vedanashamak and Shothhara
研究概览
简要总结
A Randomized parallel trial with title " A Clinical Study Of Alambushadi churna and Shatyadi Kashay in patients of Amvata vis-a-vis Rheumatoid Arthritis" in which 100 patients will be taken under 2 groups. Group A consists of Alambushadi Churna 5 gms with lukewarm water BD for 45 days .Group B contains Alambushadi Churna 5gm BD and Shatyadi Kashay 40 ml BD for 45 days. Follow up period is of 15 days.The components of Alambushadi Churna are Alambusha Gokshura Haritaki Bhibhitak Amlaki Shunthi Amrita and Shyama root. Shatyadi Kashay consists of Shati Shunthi Ativisha Vacha Devdaru Guduchi in equal parts. Patient assessment will be done on the basis of subjective and objective criteria and diagnosis according to EULAR criteria.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 30.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of age group between 30-50 years willing to participate for the trial with a diagnosis of rheumatoid arthritis using theEULAR diagnostic criteria Diagnosed cases of Amavata based on symptoms and signs described in MadhavNidana.
- •Seropositive and Seronegative both cases are included.
- •Having history of less than 5 years.
排除标准
- •Patients not willing to participate.
- •Patients having severe deformities.
- •Patients of Gouty Arthritis, Infective Arthritis, Osteoarthritis.
- •HIV, Tuberculosis, Hypertension, D.M., and other major systemic problems.
- •Pregnant & lactating women 6.Patients with major complications such as extra articular manifestations like leg ulcers, digital gangrene, Episcleritis, Endocarditis, pleural and pericardial effusions, neurological and haematologic manifestations etc.
- •will also be excluded.
结局指标
主要结局
ï‚·Both the drugs of the study are expected to be effective because these are mentioned specifically in Amvataprakran in classical text and all constituents are having properties opposite to Ama dosha Vedanashamak and Shothhara
时间窗: 45 days
次要结局
- ï‚·there can be significant reduction in modern objective parameters like RA factor Anti CCP CRP So effect of Ayurvedic text formulations on Modern parameters can be proved by the study(45 days)